Determination of factor Xa inhibition doses of low-molecular heparin, nadroparin and reviparin in urological patients | Zendy

Svetlana Pavlović | Zendy; Sladjana Zivkovic | Zendy; Goran Koraćević | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Determination of factor Xa inhibition doses of low-molecular heparin, nadroparin and reviparin in urological patients

Author(s) -

Svetlana Pavlović,

Sladjana Zivkovic,

Goran Koraćević

Publication year - 2007

Publication title -

vojnosanitetski pregled

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.123

H-Index - 19

eISSN - 2406-0720

pISSN - 0042-8450

DOI - 10.2298/vsp0708538p

Subject(s) - medicine , pulmonary embolism , low molecular weight heparin , heparin , anesthesia , surgery

The inhibition of factor Xa (FX) by the use of low-molecular heparin (LMH) is important clinical procedure in patients with moderate and high risk for the development of venous thromboembolism (VTE) and pulmonary embolism (PE). The aim of this study was to determine the level of inhibition of FXa by the use of prophylactic doses of LMH nadroparin-calcium and reviparine-sodium which were applied in urological patients with moderate risk for VTE and PE.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research